We describe a procedure for genomic difference cloning, a method for isolating sequences present in one genomic DNA population ("tester") that is absent in another ("driver"). By subtractive hybridization, a large excess of driver is used to remove sequences common to a biotinylated tester, enriching the "target" sequences that are unique to the tester. After repeated subtractive hybridization cycles, tester is separated from driver by avidin/biotin affinity chromatography, and single-stranded target is amplified by the polymerase chain reaction, rendering it double-stranded and clonable. We model two situations: the gain of sequences that result from infection with a pathogen and the loss of sequences that result from a large hemizygous deletion. We obtain 100-to 700-fold enrichment of target sequences.
One common and fundamental problem of molecular biology confronts us when two similar genomes differ and we desire to understand the difference. One simple form ofthis problem can occur when a genome becomes deleted for sequences present in another due to germ-line mutation, as can happen in genetic disease (1-3), or due to somatic mutation, as can happen during the development of cancer (4) (5) (6) . Differences can also be acquired by infection with a DNA-based pathogen. Methods for identifying and isolating sequences present in one DNA population that are absent or reduced in another are called "difference cloning." Methods for difference cloning in cDNA populations have been widely described (7) (8) (9) (10) . Only one method for the difference cloning of genomic DNA is reported in the literature. This method was first described by Lamar and Palmer (11) , who used it to clone sequences from the Y chromosome. Kunkel et al. (12) used a variation of this method to clone fragments of the Duchenne muscular dystrophy (DMD) locus, which becomes deleted in some afflicted individuals. Clones from other X-chromosome linked deletions have also been obtained by this method (13) . We describe here another method for genomic difference cloning that is at least as powerful. Although our method is not yet sufficiently powerful to isolate and define the small differences in genomes that would make it enormously useful as a tool for the study of neoplasia or infectious disease of viral origin, improvements are possible that could bring our method into that range. In its present state our method is useful for the analysis of some genetic diseases and infectious diseases of unknown origin.
We make frequent use of the following nomenclature. Two DNA populations that differ are referred to as "tester" and "driver." Tester contains "target" sequences that are not present in driver. In the procedure of Lamar and Palmer (11) , target sequences were enriched relative to the remainder of tester in the following way. Tester DNA was prepared by cleavage with Sau3A and mixed with an excess amount of randomly sheared driver DNA. DNAs were melted and reannealed to high Cot values. Double-stranded DNA (ds-DNA) was then cloned into the BamHI site of a cloning vector. In principle, only tester DNA annealed to itself would be clonable into a BamHI site. Neither driver annealed to itself, nor tester to driver, would be clonable. Thus cloned material would be enriched in target since it can form duplex only with itself. The yield of this method is poor, since it depends upon the slow reannealing of dilute tester to itself, and the theoretical enrichment cannot exceed the mass ratio of driver to tester. Yields can be improved through the use of accelerated annealing conditions, such as the phenol emulsion reannealing technique (12) (13) (14) .
Our procedure utilizes a different form of subtractive hybridization (see Fig. 1 ). Tester DNA is specially prepared (cleaved, biotinylated, and ligated to "template" oligonucleotides). Prepared tester is then mixed with an excess of randomly sheared driver, melted, and annealed. After annealing proceeds to 90% completion for driver, the remaining single-stranded DNAs (ssDNAs) are isolated. ssDNA will contain tester that is relatively enriched for target sequences, since target sequences will not have had time to reanneal. Unreannealed driver will also be present in great excess. This procedure is reiterated twice more by the addition of fresh driver, melting, annealing, and fractionation. Tester highly enriched in target sequences is then completely separated from the excess unhybridized driver by the presence of the biotin group. The resulting tester is amplified by a polymerase chain reaction (PCR) (15) and cloned. Using this procedure we obtain 100-to 700-fold enrichment of target sequences. In the following we describe the procedure in detail and demonstrate its use for two model systems. Avidin/Biotin Affinity Chromatography. Following the last solution hybridization, avidin/biotin affinity chromatography was performed (16) . The eluate of the glassmilk was adjusted to 200 mM NaCl/10 mM Tris-HCl, pH 7.5/1 mM EDTA in a volume of 100 Al, and avidin DN (Vector Laboratories) was added in excess (1 Ag) to the recovered ssDNA population. After incubation for 30 min at room temperature, the mixture was chromatographed on a 100-,l biotin-cellulose (Pierce) column. The column flow-through was cycled three times followed by washes with the loading buffer (see above), loading buffer at pH 8.5, and a buffer containing 50mM NaCl, 10 mM Tris-HCl (pH 8.5), and 1 mM EDTA. The latter buffer including 50 mM dithiothreitol and S ng of high molecular weight carrier DNA per ml was used to elute the bound DNA in 100-pl fractions.
MATERIALS AND METHODS
PCR and Cloning. One-fourth of each of the eluates from the biotin-cellulose column was subjected to amplification by PCR (15) . The PCR contained, in a volume of 50 ,l, 50 mM KCI, 10 mM Tris HCl (pH 8.4), 3 mM MgC12, 0.01% gelatin, 200 ,uM (each) dATP, dCTP, dGTP, and dTTP, 100 pmol of the PCR oligonucleotide primers (synthesized on an Applied Biosystems 380-A DNA synthesizer), and 1 unit of Thermus aquaticus (Taq) DNA polymerase (Perkin-Elmer/Cetus). The PCR primer was 5'-CTTACCATGGTAAGGATC-3'. The cycling conditions were-1.5 min of denaturation at 95°C, 3 min of annealing at 55°C, and 7 min of polymerization at 72°C. The cycle was repeated 50 times (Thermocycler, Perkin-Elmer/Cetus). The last cycle had an additional extension at 72°C for 10 min. After phenol extraction and ethanol precipitation, the amplified material was digested with Sau3A, fractionated on a Sepharose 4B column to remove low molecular weight products, concentrated by ethanol precipitation, and ligated to BamHI-cleaved and alkaline phosphatase-treated pUC118 vector (19) . Competent E. coli DH5a (20) were transformed with the ligation mix and selected for ampicillin resistance. Recombinant clones were picked and analyzed based on the blue/white color distinction.
General Methods. High molecular weight DNA from human placenta and from cell lines was isolated as described (21, 22) . Plasmid DNA was isolated by the alkaline lysis procedure (23) . For Southern blotting (24) , restriction endonuclease-digested genomic DNA (10 ,g), digested plasmid DNA, and PCR products (one-fifth of the reaction) were fractionated on agarose gels. The DNAs were transferred onto GeneScreenPlus nylon membrane (NEN), using a vacuum blotting unit (Vacugene, LKB) for 0.8% gels. A DNA to be used as a hybridization probe was labeled in vitro using a nick-translation kit (BRL). 32P-labeled single-strand DNA probes were prepared from M13 single-strand templates as described (25) . Hybridizations to labeled probes were performed in a volume of 30 ml at 68°C overnight, and hybridization and washing buffers were as described (26) . Autoradiography was performed at -70°C using Kodak XAR-5 films and intensifying screens (27 
The human-chinese hamster somatic cell hybrids GM06318B, with a human X chromosome, and GM07297, with human chromosomes 3 and X, were from the Human Genetic Mutant Cell Repository (Camden, NJ). The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 20% fetal calf serum. Two passages before extraction of the DNA the cells were subjected to selection in hypoxanthine/ aminopterin/thymidine medium. Chinese hamster ovary cells (a gift from D. Spector, Cold Spring Harbor Laboratory) were cultured in F12 medium supplemented with 10%o fetal calf serum. Human placenta of a female newborn (a gift from S. Chao, North Shore Hospital) was immediately dissected into small pieces, quickly frozen in liquid nitrogen, and stored at -700C.
PROTOCOL DESIGN
Preparation of Driver and Tester. High molecular weight driver DNA is sheared by sonication to an average size of 800 bp. High molecular weight tester DNA is cleaved with Sau3A and the 5' overhang is filled in with the Klenow fragment of the E. coli DNA polymerase I in the presence of dATP, dGTP, dCTP, and Bio-12-SS-dUTP, a biotinylated analog of dTTP (16) . The biotin moiety is linked to the uracil residue by way of a hydrolyzable disulfide group. The tester is thus flush ended and labeled with biotin. Next, double-stranded oligonucleotide template treated with polynucleotide kinase is ligated to tester. The sequence of the oligonucleotide (see Materials and Methods) is self-complementary. When the template oligomers ligate to themselves, they form a HindIII cleavage site. After the ligation of the oligomers to tester, the reaction mix is cleaved with HindIlI to destroy the products of oligomer self-ligation. This step is necessary in order that the subsequent PCR (see below) work efficiently.
Subtractive Hybridizations. Tester and driver are mixed at a mass ratio of 1:200. The DNA mixture is heat-denatured and allowed to reanneal until 90%o of driver will have formed duplex DNA. DNA is then fractionated by HAP. The single-strand fraction will contain tester sequences enriched in target and a vast excess of unreannealed driver DNA. After the addition of fresh driver DNA, this step is repeated two more times. Each round of annealing and fractionation can, in theory, enrich target over the remainder of tester by the factor 1/(1 -Fi), where Fi is the fraction of driver that reanneals in the ith cycle (and assuming tester anneals to driver with the same kinetics as driver). Thus, if driver achieves 90% reannealing in each of three rounds, target will be enriched by 1000-fold.
Separation of Tester from Driver. DNA from the subtractive hybridization steps is heavily contaminated with unreannealed driver. To isolate tester from driver, the singlestrand DNA fraction from the third round of annealing is subjected to biotin/avidin affinity chromatography. This step reduces the amount of driver by a factor of 104 to 105.
Amplification and Cloning of Target. After the affinity purification of tester, it is single stranded and present in very low concentration, due to losses of material occurring at each step of the procedure. To amplify the product of the procedure and to render it double stranded, we utilize the PCR. A PCR primer (see Materials and Methods) is added, and DNA is synthesized for 50 cycles. The PCR primer is complementary to the template oligonucleotide and in addition contains the Sau3A cleavage sequence at its 3' end. The product of the PCR reaction is cleaved by Sau3A and ligated into theE. coli plasmid vector pUC118. E. coli strain DH5a is transformed and selected on ampicillin plates containing isopropyl f-D-thiogalactopyranoside and 5-bromo-4-chloro-3-indolyl /3-D-galactopyranoside. Recombinant clones are identified by the blue/white color distinction.
RESULTS
To test our protocol we used two model systems. In the first, we modeled the gain of information in which a human cell is infected by a pathogen present at about one copy per cell. Tester DNA and driver DNA came from the identical human placenta but bacteriophage A DNA was added to tester as a known target, in a mass ratio of 1 part per 105. Thus the molar ratio of A sequences to unique human sequences in tester was about 1:1. In the second model system, we chose DNA from a male patient with DMD (28) as driver. This patient has a deletion of about one megabase of DNA from the X chromosome. Tester DNA was derived from the placenta of a female newborn. This system is representative of the case of loss of information.
Gain of Information. A DNA was added as target at single copy levels to placental DNA. The same placental DNA without A was used as driver. Several independent trials were performed. The PCR product was electrophoresed in agarose gels and Southern blotted using nick-translated A DNA as probe. Independent PCR products, even from the same subtraction, contained a random representation of Sau3A-cleaved A fragments (Fig. 2) . We do not understand this phenomenon. We also observe a strong preference for the amplification of smaller A Sau3A fragments. PCR products were ligated into vector pUC118 and used to transform DH5a. Approximately 104 recombinant clones were obtained. Several hundred white colonies (i.e., those with vectors containing inserts) were picked and pooled in groups of 10 . Plasmid DNAs were prepared from these pools, cleaved to release the insert from the vector, and analyzed by Southern blotting for the presence of A sequences. From our results we calculate that we achieved a 300-to 750-fold enrichment of A sequences in three independent trials (see Table 1 ).
Loss of Information. In the second system, tester came from placental DNA Genetics: Wieland et al. (Fig. 4) . These studies indicate that the human DNA in these two clones contains sequences derived from the X chromosome. We therefore conclude that this DNA was deleted from the DMD locus. We estimate from these results that the target sequences in tester were enriched at least 100-fold (see Table 1 ).
DISCUSSION
We have described a general procedure for genomic difference cloning and modeled it for two situations: the first in which one DNA population contains acquired sequences, and the second in which one DNA population has lost sequences. In a mathematical sense, both situations are kb equivalent. Our protocol employs iteration of cycles of subtractive hybridization during which a large excess of driver DNA is used to remove sequences common to the tester DNA, thereby enriching target sequences unique to tester. The specific experimental features that make this approach possible are (i) the use of the PCR procedure to amplify low yields of target DNA and convert it to a doublestranded, clonable form and (it) the use of biotinylation of the tester to facilitate its subsequent separation from driver after subtractive hybridization.
With this procedure we achieve about 100-to 700-fold enrichment of target sequences, which is close to the theoretical prediction. This degree of enrichment makes our procedure useful for the analysis of mammalian genomic DNA when the complexity of the target is on the order of a few megabases. Such a situation arises when we desire to isolate sequences lost in large hemizygous or homozygous deletions or when we desire to obtain probes from tissues infected with nonviral pathogens. Our procedure should also be applicable to the problem of small deletions occurring in organisms of low genomic complexity. Our procedure is not yet sufficiently powerful to be readily applied to other problems, such as the cloning of sequences lost from small homozygous deletions found in some tumor cells, or the isolation of probes from tissues infected with unknown viruses.
Several improvements in the basic methodology may be envisioned. In particular, given an enrichment of target, it should be possible to exploit the second-order kinetics of self-annealing to engineer a second stage FIG. 4. Southern blots of human-rodent cell hybrids. 32P-labeled single-strand probes of the DMD difference clones p484-67 (lanes a1-c1) and p484-98 (lanes a2-c2) were hybridized to EcoRI-cleaved DNA (10 ,ug) from the cell lines GM06318B containing only the human chromosome X (lanes b, and b2) and GM07297 containing the human chromosomes X and 3 (lanes c1 and c2). DNA from Chinese hamster ovary (lanes a1 and a2) served as a control. The DNA was separated on 0.8% agarose gels. Sizes (kb) are indicated on the left.
would further enrich target. The theoretical enrichment for a procedure based on the velocity of self-annealing is an additional N fold, where N is the fold enrichment of target achieved after the subtractive hybridization cycles. The present obstacle to applying this approach is that the product from the PCR process appears to be a stochastic sampling of DNA molecules rather than a uniform amplification of molecules present in tester prior to PCR (see Fig. 2 ).
